Early phase trials have reported promising results with spatially-fractionated radiation to deliver highly ablative radiation doses in a more tolerable grid-like versus homogenous distribution throughout large tumor volumes. A group of rad oncs, physicists, and radiobiologists have put their heads together to direct us in coordinated next steps. They conclude, recognizing this is a promising new radiation application, concerted efforts should be made by clinical trialists and vendors to standardize terminology, reporting (e.g., planning objectives and dose constraints), and hardware/software (e.g. GRID collimators) in this space. | Li, Int J Radiat Oncol Biol Phys 2023

